PUBBLICATO IL NUOVO NUMERO DEL DRUG SAFETY UPDATE



Fonte: MHRA. Maggio 2009



E' disponibile il nuovo numero del Drug Safety Update dell'agenzia inglese MHRA.

In questo numero sono trattati i seguenti argomenti:

CONTENTS
Drug safety advice
•
 Aliskiren: risk of angioedema and renal dysfunction
•
 ACE inhibitors and angiotensin II receptor antagonists: recommendations on use during breastfeeding
  Non-steroidal anti-inflammatory drugs: reminder on renal failure and impairment
Yellow Card scheme update
•
 Reporting reporting
Hot topics
•
 Orlistat: key safety information to support pharmacy availability
Stop Press
•
 New advice on oral salicylate gels for those younger than age 16 years
•
 Fortodol: risk of serious liver damage
Other information from the MHRA
•
 Patient Information Leaflet of the month: Caverject
•
 MHRA–NICE London study day for doctors in training